Charles Schwab’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.2M | Buy |
461,438
+16,009
| +4% | +$1.01M | 0.01% | 1441 |
|
|
2025
Q1 | $23.6M | Buy |
445,429
+5,179
| +1% | +$274K | ﹤0.01% | 1547 |
|
|
2024
Q4 | $24.6M | Buy |
440,250
+6,384
| +1% | +$357K | ﹤0.01% | 1584 |
|
|
2024
Q3 | $22.7M | Buy |
433,866
+5,908
| +1% | +$310K | ﹤0.01% | 1629 |
|
|
2024
Q2 | $17.6M | Buy |
427,958
+21,213
| +5% | +$871K | ﹤0.01% | 1755 |
|
|
2024
Q1 | $17.6M | Buy |
406,745
+9,060
| +2% | +$393K | ﹤0.01% | 1690 |
|
|
2023
Q4 | $18.3M | Buy |
397,685
+12,937
| +3% | +$595K | ﹤0.01% | 1646 |
|
|
2023
Q3 | $8.82M | Buy |
384,748
+34,189
| +10% | +$784K | ﹤0.01% | 1980 |
|
|
2023
Q2 | $5.78M | Buy |
350,559
+122,522
| +54% | +$2.02M | ﹤0.01% | 2181 |
|
|
2023
Q1 | $4.07M | Sell |
228,037
-1,879
| -0.8% | -$33.5K | ﹤0.01% | 2295 |
|
|
2022
Q4 | $6.7M | Buy |
229,916
+25,647
| +13% | +$747K | ﹤0.01% | 2056 |
|
|
2022
Q3 | $5.01M | Buy |
204,269
+31,539
| +18% | +$773K | ﹤0.01% | 2214 |
|
|
2022
Q2 | $717K | Sell |
172,730
-125,595
| -42% | -$521K | ﹤0.01% | 2921 |
|
|
2022
Q1 | $3.44M | Buy |
298,325
+9,219
| +3% | +$106K | ﹤0.01% | 2456 |
|
|
2021
Q4 | $2.89M | Buy |
289,106
+22,744
| +9% | +$227K | ﹤0.01% | 2575 |
|
|
2021
Q3 | $3.48M | Sell |
266,362
-1,269
| -0.5% | -$16.6K | ﹤0.01% | 2540 |
|
|
2021
Q2 | $5.24M | Buy |
267,631
+15,409
| +6% | +$302K | ﹤0.01% | 2326 |
|
|
2021
Q1 | $5.37M | Buy |
252,222
+43,349
| +21% | +$922K | ﹤0.01% | 2266 |
|
|
2020
Q4 | $6.21M | Buy |
208,873
+3,132
| +2% | +$93.1K | ﹤0.01% | 2113 |
|
|
2020
Q3 | $4.46M | Sell |
205,741
-4,383
| -2% | -$95K | ﹤0.01% | 2115 |
|
|
2020
Q2 | $4.69M | Buy |
210,124
+22,703
| +12% | +$506K | ﹤0.01% | 2061 |
|
|
2020
Q1 | $2.85M | Buy |
187,421
+3,909
| +2% | +$59.5K | ﹤0.01% | 2112 |
|
|
2019
Q4 | $4.21M | Buy |
183,512
+52,296
| +40% | +$1.2M | ﹤0.01% | 2105 |
|
|
2019
Q3 | $2.83M | Buy |
131,216
+2,877
| +2% | +$62.1K | ﹤0.01% | 2251 |
|
|
2019
Q2 | $2.82M | Buy |
128,339
+18,917
| +17% | +$416K | ﹤0.01% | 2238 |
|
|
2019
Q1 | $3M | Buy |
109,422
+4,900
| +5% | +$134K | ﹤0.01% | 2217 |
|
|
2018
Q4 | $2.81M | Sell |
104,522
-1,271
| -1% | -$34.2K | ﹤0.01% | 2191 |
|
|
2018
Q3 | $3.09M | Buy |
105,793
+58,198
| +122% | +$1.7M | ﹤0.01% | 2268 |
|
|
2018
Q2 | $1.49M | Buy |
47,595
+15,695
| +49% | +$491K | ﹤0.01% | 2463 |
|
|
2018
Q1 | $635K | Buy |
31,900
+819
| +3% | +$16.3K | ﹤0.01% | 2662 |
|
|
2017
Q4 | $904K | Buy |
+31,081
| New | +$904K | ﹤0.01% | 2538 |
|